Skip to content

mbeck

Canadian nanomedicines in the spotlight: Molecular Pharmaceutics

A new special issue of the American Chemical Society journal Molecular Pharmaceutics highlights outstanding work related to contemporary nanomedicine research in Canada. The issue, “Tiny Things, Huge Impact: Nanomedicine in Canada,”  was edited by NMIN researchers Dr. Shyh-Dar Li, Ellen Wasan, Marcel Bally, and Sarah Hedtrich, who contribute an editorial summarizing the… Read More »Canadian nanomedicines in the spotlight: Molecular Pharmaceutics

NMIN’s Founding Scientific Director receives Governor General’s Innovation Award

https://youtu.be/4eg6Y8x1JXE?list=PLh7NyssbO61nky9vVCrRsJG9izYAl5VV6Video profile of GGIA Laureate Acuitas A research team assembled in UBC approximately 40 years ago by NMIN’s Founding Scientific Director, Dr. Pieter Cullis, is receiving a 2022 Governor General’s Innovation Award for their work in developing lipid nanoparticle (LNP) systems to deliver cancer drugs to tumours and to enable… Read More »NMIN’s Founding Scientific Director receives Governor General’s Innovation Award

NMIN spin-off company NanoVation Therapeutics is expanding into UK

NMIN spin-off company NanoVation Therapeutics™ (NTx) is growing rapidly and is expanding its overseas operations with the launch of its first NanoVation GENErator™ in the UK, based at the Harwell Science and Innovation Campus near Oxford. The Honourable François-Philippe Champagne PC, MP (Minister of Innovation, Science and Industry) visits NanoVation’s… Read More »NMIN spin-off company NanoVation Therapeutics is expanding into UK